22.01.20152759
There are little data on the efficacy of new oral anticoagulants (NOAC) in this setting.
21.01.20151471
The University of Michigan Frankel Cardiovascular Center recently discharged a 24-year old patient with a total artificial heart, allowing him to return home without a human heart while he waits for a heart transplant.
20.01.20151956
Cerebrovascular disease is often associated with Alzheimer’s disease, and especially with cognitive decline, according to researchers.
19.01.20151840
Portola Pharmaceuticals announced topline results of the phase 3 ANNEXA-R study demonstrating that andexanet alfa, an antidote to the anticoagulant effects of Factor Xa inhibitors, met the primary endpoint with high statistical significance.
16.01.20151740
A systematic review and meta-analysis of 25 randomized controlled trials yielded no significant association between statin therapy and cognitive impairment.
16.01.20151538
Risks associated with noncardiac surgery are highest in the first 6 months after coronary stent implantation, and a new study suggests that delaying noncardiac surgery for at least 6 months may yield improved outcomes in patients after stenting.
14.01.20152019
Sanofi and Regeneron Pharmaceuticals Inc. announced that the phase 3 ODYSSEY CHOICE I and CHOICE II trials had each met their primary efficacy endpoints for monthly treatment with alirocumab in patients with hypercholesterolemia.